Do thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia?
Thrombocytopenia and thrombocytosis are associated with mortality in patients hospitalized with CAP. When evaluating an initial CBC test in patients with CAP, an abnormal platelet count is a better predictor of outcome than an abnormal leukocyte count.
In this study, adding genetic information to a previously validated clinic + biological score does not seem to improve the prediction of T2DM.